Christopher Dibble to Hemangioma, Cavernous, Central Nervous System
This is a "connection" page, showing publications Christopher Dibble has written about Hemangioma, Cavernous, Central Nervous System.
Connection Strength
0.451
-
Baxter SS, Dibble CF, Byrd WC, Carlson J, Mack CR, Saldarriaga I, Bencharit S. Role of cytoskeletal proteins in cerebral cavernous malformation signaling pathways: a proteomic analysis. Mol Biosyst. 2014 Jul; 10(7):1881-9.
Score: 0.125
-
Edelmann AR, Schwartz-Baxter S, Dibble CF, Byrd WC, Carlson J, Saldarriaga I, Bencharit S. Systems biology and proteomic analysis of cerebral cavernous malformation. Expert Rev Proteomics. 2014 Jun; 11(3):395-404.
Score: 0.122
-
Richardson BT, Dibble CF, Borikova AL, Johnson GL. Cerebral cavernous malformation is a vascular disease associated with activated RhoA signaling. Biol Chem. 2013 Jan; 394(1):35-42.
Score: 0.112
-
Borikova AL, Dibble CF, Sciaky N, Welch CM, Abell AN, Bencharit S, Johnson GL. Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype. J Biol Chem. 2010 Apr 16; 285(16):11760-4.
Score: 0.092